CEFAXONE FOR INJECTION 1 gvial

Χώρα: Σιγκαπούρη

Γλώσσα: Αγγλικά

Πηγή: HSA (Health Sciences Authority)

Αγόρασέ το τώρα

Κατεβάστε Αρχείο Π.Χ.Π. (SPC)
07-02-2022

Δραστική ουσία:

CEFTRIAXONE SODIUM EQV CEFTRIAXONE

Διαθέσιμο από:

ZYFAS PHARMA PTE LTD

Φαρμακολογική κατηγορία (ATC):

J01DD04

Δοσολογία:

1 g/vial

Φαρμακοτεχνική μορφή:

INJECTION, POWDER, FOR SOLUTION

Σύνθεση:

CEFTRIAXONE SODIUM EQV CEFTRIAXONE 1 g/vial

Οδός χορήγησης:

INTRAMUSCULAR

Τρόπος διάθεσης:

Prescription Only

Κατασκευάζεται από:

SHIN POONG PHARMACEUTICAL CO LTD

Καθεστώς αδειοδότησης:

ACTIVE

Ημερομηνία της άδειας:

1999-09-11

Αρχείο Π.Χ.Π.

                                Third Generation Cephalosporins
CEFAXONE INJECTION
500MG, 1G
CEFTRIAXONE SODIUM
■
COMPOSITION
: Each vial contains
Ceftriaxone sodium……..……....... 500mg (potency)
………………… 1g (potency)
■ DESCRIPTION
CEFAXONE INJECTION is a white to pale yellow powder
in a colorless transparent vial. Each box comes
with 10 vials and a package insert.
■ PHARMACOLOGY
The bactericidal activity of ceftriaxone results from inhibition of
bacterial cell wall synthesis.
Ceftriaxone exerts in vitro activity against a wide range of
gram-negative and gram-positive
micro-organisms. Ceftriaxone is highly stable to most ß-lactamases,
both penicillinases and
cephalosporinases, of gram-positive and gram-negative bacteria.
Ceftriaxone is usually active
against the following micro-organisms in vitro and in clinical
infections.
Gram-positive aerobes
Staphylococcus aureus
(methicillin-sensitive), Staphylococci coagulase-negative,
Streptococcus
pyogenes
(ß-hemolytic, group A),
Streptococcus agalactiae
(ß-hemolytic, group B), ß-hemolytic
Streptococci (non-group A or B),
Streptococcus viridans, Streptococcus pneumoniae.
Note
: Methicillin-resistant
Staphylococcus
spp. is resistant to cephalosporins, including ceftriaxone.
In general,
Enterococcus faecalis, Enterococcus faecium
and
Listeria monocytogenes
are resistant.
Gram-negative aerobes
Acinetobacter lwoffi, Acinetobacter anitratus
(mostly A. baumanii)
*, Aeromonas hydrophila,
Alcaligenes faecalis, Alcaligenes odorans, Alcaligenes
-like bacteria
, Borrelia burgdorferi,
Capnocytophaga
spp.
, Citrobacter diversus (
including C.
amalonaticus), Citrobacter freundii*,
Escherichia coli, Enterobacter aerogenes*, Enterobacter cloacae*,
Enterobacter
spp. (other)*
,
Haemophilus ducreyi, Haemophilus influenzae, Haemophilus
parainfluenzae, Hafnia alvei, Klebsiella
oxytoca, Klebsiella pneumoniae**, Moraxella catarrhalis
(former
Branhamella catarrhalis), Moraxella
osloensis, Moraxella
spp. (other),
Morganella morganii, Neisseria gonorrhoea, Neisseria
meningitidis, Pasteurella multoci
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Αναζήτηση ειδοποιήσεων που σχετίζονται με αυτό το προϊόν

Προβολή ιστορικού εγγράφων